Literature DB >> 8698477

Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters.

B K Du Chateau1, D M England, S M Callister, L C Lim, S D Lovrich, R F Schell.   

Abstract

The mechanism(s) by which Lyme arthritis is induced has not been elucidated. In this study, we showed that macrophages have a direct, effector role in the pathogenesis of Lyme arthritis. Severe destructive arthritis was induced in recipients of macrophages obtained from Borrelia burgdorferi-vaccinated and nonvaccinated hamsters exposed to Formalin-inactivated B. burgdorferi in vitro and then challenged with the Lyme spirochete. Swelling of the hind paws was detected within 8 h of infection, increased rapidly, and peaked at 21 h. This initial swelling decreased, and by day 4 only slight swelling was detected. Severe swelling of the hind paws was detected 8 days after infection and increased rapidly, with peak swelling occurring on day 11. Histopathologic examination affirmed that macrophages exposed to Formalin-inactivated spirochetes induced a severe destructive Lyme arthritis. The onset and severity of the severe destructive arthritis were dependent on the number of macrophages transferred. By contrast, macrophages not exposed to Formalin-inactivated B. burgdorferi failed to induce severe destructive arthritis in recipients after challenge with B. burgdorferi. Similarly, severe destructive arthritis was not detected in recipients of macrophages injected with spirochetal growth medium. Our results also showed that transferred macrophages could not protect hamsters from infection with B. burgdorferi, as spirochetes were readily recovered from their tissues when cultured. These findings demonstrate that macrophages exposed to B. burgdorferi are directly involved in the induction of Lyme arthritis.

Entities:  

Mesh:

Year:  1996        PMID: 8698477      PMCID: PMC174108          DOI: 10.1128/iai.64.7.2540-2547.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

Authors:  D R Bertolini; G E Nedwin; T S Bringman; D D Smith; G R Mundy
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

2.  Monoclonal antibodies to hamster class II MHC molecules distinguish T and B cells.

Authors:  P L Witte; J W Streilein
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

3.  Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor.

Authors:  J L Benach; H B Fleit; G S Habicht; J L Coleman; E M Bosler; B P Lane
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

4.  Lyme disease spirochetes induce human and murine interleukin 1 production.

Authors:  G S Habicht; G Beck; J L Benach; J L Coleman; K D Leichtling
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

5.  Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis.

Authors:  A C Steere; A Gibofsky; M E Patarroyo; R J Winchester; J A Hardin; S E Malawista
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

6.  Human phagocyte interactions with the Lyme disease spirochete.

Authors:  P K Peterson; C C Clawson; D A Lee; D J Garlich; P G Quie; R C Johnson
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.

Authors:  B M Thomson; G R Mundy; T J Chambers
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

8.  Description of phenotypically distinct T-lymphocyte subsets which mediate helper/DTH and cytotoxic functions in the Syrian hamster.

Authors:  P L Witte; J Stein-Streilein; J W Streilein
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

9.  Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.

Authors:  A Keane-Myers; S P Nickell
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

10.  Phagocytic cell responses to in vivo and in vitro exposure to the Lyme disease spirochete.

Authors:  J L Benach; G S Habicht; B L Gocinski; J L Coleman
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  7 in total

Review 1.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

Review 2.  Lyme arthritis: current concepts and a change in paradigm.

Authors:  Dean T Nardelli; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

3.  Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.

Authors:  B K DuChateau; J R Jensen; D M England; S M Callister; S D Lovrich; R F Schell
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Pattern of proinflammatory cytokine induction in RAW264.7 mouse macrophages is identical for virulent and attenuated Borrelia burgdorferi.

Authors:  Guiqing Wang; Mary M Petzke; Radha Iyer; Hongyan Wu; Ira Schwartz
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

5.  Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection.

Authors:  C R Brown; S L Reiner
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 6.  Hamster and murine models of severe destructive Lyme arthritis.

Authors:  Erik Munson; Dean T Nardelli; Brian K Du Chateau; Steven M Callister; Ronald F Schell
Journal:  Clin Dev Immunol       Date:  2012-02-22

Review 7.  A joint effort: The interplay between the innate and the adaptive immune system in Lyme arthritis.

Authors:  Michelle A E Brouwer; Freek R van de Schoor; Hedwig D Vrijmoeth; Mihai G Netea; Leo A B Joosten
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.